Detalles de la búsqueda
1.
Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
Eur Arch Psychiatry Clin Neurosci
; 273(7): 1477-1487, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36574032
2.
Local and global effects of sedation in resting-state fMRI: a randomized, placebo-controlled comparison between etifoxine and alprazolam.
Neuropsychopharmacology
; 2024 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-38822128
3.
The translocator protein 18kDa ligand etifoxine in the treatment of depressive disorders-a double-blind, randomized, placebo-controlled proof-of-concept study.
Trials
; 25(1): 274, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38650030
4.
Differential effects of the translocator protein 18 kDa (TSPO) ligand etifoxine and the benzodiazepine alprazolam on startle response to predictable threat in a NPU-threat task after acute and short-term treatment.
Psychopharmacology (Berl)
; 239(7): 2233-2244, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35278124
5.
Telephone health coaching with exercise monitoring using wearable activity trackers (TeGeCoach) for improving walking impairment in peripheral artery disease: study protocol for a randomised controlled trial and economic evaluation.
BMJ Open
; 10(6): e032146, 2020 06 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32503866
Resultados
1 -
5
de 5
1
Próxima >
>>